NICOLE LUCERO: Open Payments
NPI 1417679556 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 50 payments from 16 companies in 2025. Trend: 2023 $534 · 2024 $783 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $262 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| Lilly USA, LLC | 3 | $54 |
| Novo Nordisk Inc | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Acella Pharmaceuticals, LLC | 2 | $36 |
| Lundbeck LLC | 1 | $29 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
Products named: QULIPTA, VRAYLAR, AUSTEDO XR, MOUNJARO, REXULTI, Kerendia, NP Thyroid 60, UBRELVY.
Industry payments across NM — which companies pay providers there.
